Equibles does not estimate personal net worth.
Get an email with a short summary when Eton Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ETON alertsIpek Erdogan-Trinkaus has spoken on 3 earnings calls across 1 company, most recently for Eton Pharmaceuticals, Inc. on November 5, 2026. Eton Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Eton Pharmaceuticals, Inc. includes Sean Brynjelsen (CEO and Board Member), Norbert G. Riedel (Chairman), James Gruber (CFO) and 5 others.
“Sure, I think basically we historically mentioned that There are around 8,000 patients historically on hemangiole, so we are based on our current, this is before Ethan time, based on our current run rate, we are feeling pretty good that not only we brought those death patients phase over, we are already seeing growth…”
“For the first part of your question on Hemangio, I think a few things to note there for the kind of… Thank you.”
“A few things that are very similar and a few things that are different.”
Proxy statement
Start not stated–present
Last confirmed April 24, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
